JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB124595

Recombinant Human EXOSC5/CML28 protein (His tag N-Terminus)

Be the first to review this product! 리뷰 제출

|

(1 출판물)

Recombinant Human EXOSC5/CML28 protein (His tag N-Terminus) is a Human Full Length protein, in the 1 to 235 aa range, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE, Mass Spec.

대체 명칭 보기

CML28, RRP46, EXOSC5, Exosome complex component RRP46, Chronic myelogenous leukemia tumor antigen 28, Exosome component 5, Ribosomal RNA-processing protein 46, p12B

1 이미지
SDS-PAGE - Recombinant Human EXOSC5/CML28 protein (His tag N-Terminus) (AB124595)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant Human EXOSC5/CML28 protein (His tag N-Terminus) (AB124595)

15% SDS-PAGE showing ab124595 (3μg).

주요 정보

Purity

>90% SDS-PAGE

ab124595 is purified using conventional chromatography techniques.

발현 시스템

Escherichia coli

Tags

His tag N-Terminus

Applications

Mass Spec, SDS-PAGE

applications

Biologically active

No

Accession

Animal free

No

Carrier free

No

Species

Human

보관 버퍼

pH: 7.4 Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1.17% Sodium chloride, 0.03% (R*,R*)-1,4-Dimercaptobutan-2,3-diol

storage-buffer

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "Mass Spec": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

제품 세부 정보

This product was previously labelled as EXOSC5

서열 정보

[{"linker":null,"sequence":"MGSSHHHHHHSSGLVPRGSHMMEEETHTDAKIRAENGTGSSPRGPGCSLRHFACEQNLLSRPDGSASFLQGDTSVLAGVYGPAEVKVSKEIFNKATLEVILRPKIGLPGVAEKSRERLIRNTCEAVVLGTLHPRTSITVVLQVVSDAGSLLACCLNAACMALVDAGVPMRALFCGVACALDSDGTLVLDPTSKQEKEARAVLTFALDSVERKLLMSSTKGLYSDTELQQCLAAAQAASQHVFRFYRESLQRRYSKS","proteinLength":"Full Length","predictedMolecularWeight":"27.5 kDa","actualMolecularWeight":null,"aminoAcidEnd":235,"aminoAcidStart":1,"nature":"Recombinant","expressionSystem":"Escherichia coli","accessionNumber":"Q9NQT4","tags":[{"tag":"His","terminus":"N-Terminus"}]}]

특성 및 보관 정보

제형
Liquid
배송 시 보관 조건
Blue Ice
적절한 단기 보관 조건
-20°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle
False

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

EXOSC5 also known as CML28 is a core component of the exosome complex an important multiprotein machinery involved in RNA processing and degradation. EXOSC5 has a molecular mass of approximately 34 kDa and is expressed in a wide range of tissues. It functions as a scaffold within the exosome complex interacting with other exosome subunits to maintain the stability and structure of the complex.
Biological function summary

EXOSC5 is important for the normal function of the RNA exosome complex which plays a central role in 3'-to-5' RNA processing and degradation. The exosome complex is essential for removing defective RNA molecules and managing RNA stability. EXOSC5 acts as a bridge between the core exosome and additional cofactors that enhance the exosome's specific functions. This regulation ensures appropriate cellular RNA levels impacting gene expression and integrity.

Pathways

EXOSC5 is involved in the RNA surveillance pathway which monitors and degrades aberrant RNA transcripts in the cell. The pathway ensures that only properly processed RNAs are translated into proteins. Within this framework EXOSC5 interacts with RRP44 a catalytic component of the exosome bolstering its activity in degrading faulty RNAs. The balance of RNA processing and degradation that EXOSC5 supports is vital in maintaining cellular homeostasis.

Abnormalities in EXOSC5 have been linked to autoimmune diseases and cancers. Autoimmune responses may target EXOSC5 leading to disrupted RNA processing. Moreover alterations in EXOSC5 expression or function can contribute to oncogenesis by impacting the cell cycle and apoptosis. In cancers interactions between EXOSC5 and the protein p53 suggest a connection in cell survival pathways highlighting EXOSC5's potential as a therapeutic target in cancer treatments.

일반 정보

기능

Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes (PubMed : 11782436, PubMed : 21269460). In vitro, EXOSC5 does not bind or digest single-stranded RNA and binds to double-stranded DNA without detectable DNase activity (PubMed : 20660080).

서열 유사성

Belongs to the RNase PH family.

Subcellular localisation

Nucleus

제품 프로토콜

타겟 정보

Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes (PubMed : 11782436, PubMed : 21269460). In vitro, EXOSC5 does not bind or digest single-stranded RNA and binds to double-stranded DNA without detectable DNase activity (PubMed : 20660080).
See full target information EXOSC5

제품이 사용된 논문 (1)

Recent publications for all applications. Explore the 전체 목록 and refine your search

Cellular physiology and biochemistry : internation 31:659-72 PubMed23711492

2013

Klotho ameliorates chemically induced endoplasmic reticulum (ER) stress signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Srijita Banerjee,Yanhua Zhao,Partha S Sarkar,Kevin P Rosenblatt,Ronald G Tilton,Sanjeev Choudhary
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com